STAT+: Up and down the ladder: The latest comings and goings
Stat News • 2/27/2026
Summary
The article titled "STAT+: Up and down the ladder: The latest comings and goings" reports on new hires, departures, promotions, and transfers within the pharmaceutical industry. It provides updates on the latest personnel changes in the sector.
Advertisement
Lindy Score Breakdown (V4.2)
51d
Age
1
Sources
from cluster
1228
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1228/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1228/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 51 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Up and down the ladder: The latest comings and goings
Stat News • 2 days ago
STAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions
Stat News • 2 days ago
STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows
Stat News • 2 days ago
STAT+: FDA eyes expanding testosterone therapy for libido
Stat News • 2 days ago
STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Stat News • Today
STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 2 days ago
The deadly consequences of ICE detention
Stat News • 2 days ago
Opinion: Don’t believe headlines saying that vaccine skepticism is widespread
Stat News • 2 days ago
How Trump is pushing psychedelics reform through the health agencies
Stat News • 1 day ago